October 7, 2023
CD19-directed CAR T-cell therapy Breyanzi has been approved by the European Commission (EC) based on significant results from a lymphoma Phase III trial. The European Commission […]
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more